| 中山醫學大學 |
2017-08-28 |
Benefits of incorporating the adaptive dynamic range optimization amplification scheme into an assistive listening device for people with mild or moderate hearing loss
|
Hung-Yue Chang;Ching-Hsing Luo;Tun-Shin Lo;,Hsiao-Chuan Chen;,Kuo-You Huang;Wen-Huei Liao;Mao-Chang Su;Shu-Yu Liu;Nan-Mai Wang |
| 國立成功大學 |
2018 |
Benefits of incorporating the adaptive dynamic range optimization amplification scheme into an assistive listening device for people with mild or moderate hearing loss
|
Chang, H.-Y.;Luo, C.-H.;Lo, T.-S.;Chen, H.-C.;Huang, K.-Y.;Liao, W.-H.;Su, M.-C.;Liu, S.-Y.;Wang, N.-M. |
| 臺大學術典藏 |
2018-09-10T08:37:23Z |
Benefits of international student exchange and international cooperation
|
Chang, Y.-T.;Chang, M.-H.; Chang, Y.-T.; Chang, M.-H.; MING-HUEI CHANG |
| 臺大學術典藏 |
2020-07-24T03:43:05Z |
Benefits of international student exchange and international cooperation
|
MING-HUEI CHANG; Chang, M.-H.; Chang, Y.-T.; Chang, Y.-T.;Chang, M.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:04Z |
Benefits of long-term therapy with nucleos(t)ide analogues in treatment-na?ve patients with chronic hepatitis B
|
Wei L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:00:55Z |
Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naive patients with chronic hepatitis B
|
Wei, L.;Kao, J.-H.; JIA-HORNG KAO |
| 國立臺灣大學 |
2015 |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency
|
Lee, Ni-Chung; Muramatsu, Shin-ichi; Chien, Yin-Hsiu; Liu, Wen-Shin; Wang, Wei-Hua; Cheng, Chia-Hao; Hu, Meng-Kai; Chen, Pin-Wen; Tzen, Kai-Yuan; Byrne, Barry J.; Hwu, Wuh-Liang; 胡務亮; 曾凱元; 李妮鍾; 簡穎秀 |
| 臺大學術典藏 |
2020-12-09T01:38:23Z |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency
|
NI-CHUNG LEE; Muramatsu S.-I.; Chien Y.-H.; Liu W.-S.; Wang W.-H.; Cheng C.-H.; Hu M.-K.; Chen P.-W.; Tzen K.-Y.; Byrne B.J.; Hwu W.-L. |
| 臺大學術典藏 |
2020-12-16T02:25:22Z |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency
|
Lee N.-C.; Muramatsu S.-I.; Chien Y.-H.; Liu W.-S.; Wang W.-H.; Cheng C.-H.; Hu M.-K.; Chen P.-W.; Tzen K.-Y.; Byrne B.J.; WUH-LIANG HWU |
| 臺大學術典藏 |
2015 |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency
|
Hwu W.-L.; Byrne B.J.; Lee N.-C.; Muramatsu S.-I.; YIN-HSIU CHIEN; Liu W.-S.; Wang W.-H.; Cheng C.-H.; Hu M.-K.; Chen P.-W.; Tzen K.-Y. |
| 臺大學術典藏 |
2021-03-18T05:59:00Z |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency
|
Lee N.-C.; Muramatsu S.-I.; Chien Y.-H.; Liu W.-S.; Wang W.-H.; Cheng C.-H.; Hu M.-K.; Chen P.-W.; KAI-YUAN TZEN; Byrne B.J.; Hwu W.-L. |
| 臺北醫學大學 |
2002 |
Benefits of personal digital assistance in decreasing prescribing errors: preliminary experience from a tertiary care hospital.
|
王宗倫; Wang TL; Chang H; ; ; ; |
| 國立臺灣大學 |
2010 |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
林裕峯; 陳永銘; 洪冠予; 朱宗信; 甘偉志; 黃致遠; 林水龍; 高芷華; 黃政文; 姜文智; 嚴崇仁; 蔡敦仁; 吳寬墩; 吳明修; LIN, YU-FENG; CHEN, YUNG-MING; HUNG, KUAN-YU; CHU, TZONG-SHINN; KAN, WEI-CHIH; HUANG, CHIH-YUAN; LIN, SHUEI-LIONG; KAO, TZE-WAH; HUANG, JENQ-WEN; CHIANG, WEN-CHIH; YEN, CHUNG-JEN; TSAI, TUN-JUN; WU, KWAN-DUN; WU, MING-SHIOU |
| 臺大學術典藏 |
2018-09-10T08:03:55Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
WEN-CHIH CHIANG; JENQ-WEN HUANG; KUAN-YU HUNG; YUNG-MING CHEN; Lin, Y.-F. and Chen, Y.-M. and Hung, K.-Y. and Chu, T.-S. and Kan, W.-C. and Huang, C.-Y. and Lin, S.-L. and Kao, T.-W. and Huang, J.-W. and Chiang, W.-C. and Yen, C.-J. and Tsai, T.-J. and Wu, K.-D. and Wu, M.-S.; TZONG-SHINN CHU; YU-FENG LIN; MING-SHIOU WU; CHUNG-JEN YEN; SHUEI-LIONG LIN; TUN-JUN TSAI |
| 臺大學術典藏 |
2021-07-20T03:15:43Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; TZONG-SHINN CHU; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-10-14T06:31:01Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu M.-S.; Wu K.-D.; Tsai T.-J.; CHUNG-JEN YEN; Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C. |
| 臺大學術典藏 |
2020-11-27T03:25:01Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.;Chen Y.-M.;Kuan-Yu Hung;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Lin Y.-F.; Chen Y.-M.; KUAN-YU HUNG; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:36Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu M.-S.; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; JENQ-WEN HUANG; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Jenq-Wen Huang;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T08:11:52Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
MING-SHIOU WU; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Ming-Shiou Wu |
| 臺大學術典藏 |
2020-12-24T08:38:30Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Wen-Chih Chiang;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Wu M.-S.; Wu K.-D.; Tsai T.-J.; Yen C.-J.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; WEN-CHIH CHIANG |
| 臺大學術典藏 |
2021-01-12T03:32:23Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; SHUEI-LIONG LIN; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T06:30:39Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Chiang W.-C.; Huang J.-W.; Kao T.-W.; Huang C.-Y.; Lin S.-L.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; YUNG-MING CHEN; Lin Y.-F.;Yung-Ming Chen;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Lin Y.-F.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2021-06-25T07:22:04Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
YU-FENG LIN; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:43:47Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu K.-D.; Wu M.-S.; TUN-JUN TSAI; Yen C.-J.; Chiang W.-C.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F. |
| 臺大學術典藏 |
2021-08-20T04:14:19Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Chen Y.-M.; KUAN-YU HUNG; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
